Gene · 6581
Papers1,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural basis for prostaglandin and drug transport via SLCO2A1. | Nat Commun | 2026 | 41862483 | PubTator, text mining | PubMed |
| The 2-Amino-3,4-dihydroquinazoline Molecular Scaffold as Novel OCT3 Inhibitor. | ACS Chem Neurosci | 2026 | 41856981 | PubTator, text mining | PubMed |
| SLC22A3 deficiency leads to cognitive impairment through the cardio-neuroinflammatory axis mediated HA/H1R/NLRP3 pathway in heart failure mice. | Redox Biol | 2026 | 41833108 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Bulk RNA-seq, Machine Learning, Mendelian Randomization, and Single-Cell Sequencing Unravels SLC22A3 as a Solute Carrier Superfamily-Associated Biomarker in Atherosclerosis. | J Cardiovasc Transl Res | 2026 | 41806154 | PubTator, text mining | PubMed |
| From Acute Stress to Long-Term Dysregulation: Changes in Hematological and Hormonal Parameters in the Long-Term Post-Stress Period in a Modified SPS&S Model. | Biomedicines | 2026 | 41751255 | PubTator, text mining | PubMed |
| Metformin-Mediated Glycaemic Regulation as a Potential Strategy for Breast Cancer Prevention. | Cancer Med | 2026 | 41603225 | PubTator, text mining | PubMed |
| Enhanced Polarity of Sulfonamide Metformin Derivatives Increases Cellular Uptake and Apoptosis-Inducing Effects in Human Breast Cancer Cells. | Mol Pharm | 2026 | 40977543 | PubTator, text mining | PubMed |
| MegaEye: Applying multiple machine learning approaches to identify oral compounds with ocular bioactivity. | Artif Intell Life Sci | 2025 | 41531456 | PubTator, text mining | PubMed |
| Proton-Pump Inhibitor Use and Gastrointestinal Disease Risk: A Mendelian Randomization Study of Omics and Pharmacological Pathways. | FASEB J | 2025 | 41420535 | PubTator, text mining | PubMed |
| Integrative functional genomics reveals transcriptional regulatory function of risk alleles for metabolic liver disease. | Res Sq | 2025 | 41282202 | PubTator, text mining | PubMed |
| Deciphering the structural impact of norepinephrine analog radiopharmaceuticals on organic cation transporter affinity. | Biomed Pharmacother | 2025 | 41172956 | PubTator, text mining | PubMed |
| PACT is requisite for prostate cancer cell proliferation. | Sci Rep | 2025 | 41120564 | PubTator, text mining | PubMed |
| Identification of Mitophagy-Related Genes and Analysis of Immune Infiltration in Atherosclerosis. | J Inflamm Res | 2025 | 41064491 | PubTator, text mining | PubMed |
| New Machine Learning Models for Predicting the Organic Cation Transporters OCT1, OCT2, and OCT3 Uptake. | ACS Omega | 2025 | 41048715 | PubTator, text mining | PubMed |
| Identifying survival subtypes with autoencoder using multiple types of high-dimensional genomic data from studies of glioblastoma multiforme. | Brief Bioinform | 2025 | 41016009 | PubTator, text mining | PubMed |
| Pharmacogenetics and Molecular Ancestry of SLC22A1, SLC22A2, SLC22A3, ABCB1, CYP2C8, CYP2C9, and CYP2C19 in Ecuadorian Subjects with Type 2 Diabetes Mellitus. | Pharmaceuticals (Basel) | 2025 | 41011206 | PubTator, text mining | PubMed |
| Improved circulating tumor DNA identification for detection of esophageal squamous cell carcinoma by enzymatic methyl sequencing and hybrid neural network. | Sci Rep | 2025 | 41006474 | PubTator, text mining | PubMed |
| Diversity of human choline transporters: substrate specificity, kinetic properties, and inhibitor sensitivity. | Biochem Pharmacol | 2025 | 40972734 | Swiss-Prot, curated | PubMed |
| Controlling nephron precursor differentiation to generate proximal-biased kidney organoids with emerging maturity. | Nat Commun | 2025 | 40885711 | PubTator, text mining | PubMed |
| Influence of Organic Cation Transporter 3 (SLC22A3) Genetic Polymorphisms on Antidepressant Maintenance Doses in Japanese Patients with Depression. | Neuropsychobiology | 2025 | 40875702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6581/papers?page=2